Ireland
--:--IST
Recruiting Observational

Periodontal Pathogens and Inflammatory Biomarkers in Missed Abortion

NCT07864220 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08-01
Last updated
2026-10-07

Condition(s) studied

Missed AbortionPeriodontitis

Study summary

This observational case-control study will investigate whether periodontal infection and inflammation are associated with missed abortion in pregnancies without detected major fetal chromosomal abnormalities.

A total of 160 pregnant women aged 18 to 40 years and at 20 weeks of gestation or earlier are planned to be enrolled. The study will include 80 women diagnosed with missed abortion and 80 women with an ongoing uncomplicated pregnancy matched according to age and gestational week.

Participants will undergo a clinical periodontal examination, and unstimulated saliva samples will be collected. Saliva will be analyzed for selected periodontal bacteria, including Porphyromonas gingivalis, Fusobacterium nucleatum, and Tannerella forsythia, as well as inflammatory biomarkers.

Serum obtained from blood samples already collected as part of routine obstetric care will be used to measure inflammatory biomarkers, including IL-1β, IL-6, TNF-α, CRP, MMP-8, and prostaglandin E2. No additional blood sample will be collected solely for this study. Routine complete blood count results will also be used to calculate systemic inflammatory indices.

For participants with missed abortion, study samples and periodontal assessments will be obtained after the diagnosis has been confirmed and before uterine evacuation or medical treatment. Routine fetal genetic test results will be reviewed, and cases with detected chromosomal abnormalities included in the clinical genetic assessment will be excluded from the main analysis.

The study aims to determine whether periodontal pathogen burden, periodontal disease, and local and systemic inflammatory responses differ between women with missed abortion and women with ongoing uncomplicated pregnancies.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Female participants aged 18-40 years Pregnancy at 20 weeks of gestation or earlier For the case group: diagnosis of missed abortion For the control group: ongoing uncomplicated pregnancy Provision of written informed consent Exclusion Criteria: * Detected fetal chromosomal or genetic abnormality Current smoking Alcohol use Diabetes mellitus Hypertension Autoimmune disease Antibiotic use within the previous 3 months Induced abortion Multiple pregnancy

Primary outcome measure(s)

  • Salivary Porphyromonas gingivalis Burden — Baseline
    Porphyromonas gingivalis burden in unstimulated whole saliva will be quantitatively assessed using real-time polymerase chain reaction (qPCR). Bacterial burden will be reported using the quantitative output of the assay, such as bacterial copy number or bacterial load normalized to total bacterial load.
  • Salivary Fusobacterium nucleatum Burden — Baseline
    Fusobacterium nucleatum burden in unstimulated whole saliva will be quantitatively assessed using real-time polymerase chain reaction (qPCR). Bacterial burden will be reported using the quantitative output of the assay, such as bacterial copy number or bacterial load normalized to total bacterial load.
  • Salivary Tannerella forsythia Burden — Baseline
    Tannerella forsythia burden in unstimulated whole saliva will be quantitatively assessed using real-time polymerase chain reaction (qPCR). Bacterial burden will be reported using the quantitative output of the assay, such as bacterial copy number or bacterial load normalized to total bacterial load.

Trial sites (1)

FacilityCityRegionStatus
Necmettin Erbakan University Faculty of Medicine, Department of Obstetrics and Gynecology Konya Konya Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07864220 on ClinicalTrials.gov ↗ ← All trials in Turkey